Literature DB >> 23775259

Treatment of pulmonary hypertension caused by left heart failure with pulmonary arterial hypertension-specific therapies: lessons from the right and LEPHT.

Lewis J Rubin.   

Abstract

Entities:  

Keywords:  Editorials; hypertension, pulmonary

Mesh：

Substances：

Year:  2013        PMID： 23775259     DOI： 10.1161/CIRCULATIONAHA.113.004194

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  New insights into the role of soluble guanylate cyclase in blood pressure regulation.

Authors:  Emmanuel Buys; Patrick Sips
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

Review 2.  Pulmonary hypertension caused by pulmonary venous hypertension.

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

3.  Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease.

Authors:  Daniel P Zimmer; Courtney M Shea; Jenny V Tobin; Boris Tchernychev; Peter Germano; Kristie Sykes; Ali R Banijamali; Sarah Jacobson; Sylvie G Bernier; Renee Sarno; Andrew Carvalho; Yueh-Tyng Chien; Regina Graul; Emmanuel S Buys; Juli E Jones; James D Wakefield; Gavrielle M Price; Jennifer G Chickering; G Todd Milne; Mark G Currie; Jaime L Masferrer
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.